Side-by-side comparison of AI visibility scores, market position, and capabilities
Caresyntax is the leading surgical intelligence platform serving 30,000+ surgical professionals across 3,000+ ORs globally; raised $302M total including $180M in 2026 with Symbiotic Capital, BlackRock Innovation Capital, and Optum Ventures.
Caresyntax is a surgical data and analytics company that captures, integrates, and analyzes multimodal data — including OR video, imaging, device outputs, and clinical records — to improve patient outcomes, surgical performance, and operating room efficiency. The company serves more than 30,000 surgical professionals across more than 3,000 operating rooms globally, with customers spanning hospitals and health systems in the US and EMEA. Its platform provides real-time intraoperative guidance, post-operative performance analytics, risk stratification tools, and resource optimization insights for surgical teams, hospital administrators, and medical device companies.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.